Literature DB >> 22266404

Identification of suitable reference genes for gene expression measurement in uterine sarcoma and carcinosarcoma tumors.

Magdalena Kowalewska1, Anna Danska-Bidzinska, Elwira Bakula-Zalewska, Mariusz Bidzinski.   

Abstract

OBJECTIVE: To date no suitable reference genes have been identified in carcinosarcomas and non-epithelial malignant tumors of corpus uteri for normalizing real-time RT-PCR (qRT-PCR) assays. The purpose of this study was to select appropriate references for gene expression studies in these tumors.
MATERIALS AND METHODS: We used RNA extracts from 75 tissue samples, representing 50 tumors and 25 fragments of normal uterine tissues obtained from 50 patients treated for mixed tumors, smooth muscle sarcoma and stromal sarcoma of the uterus. qRT-PCR for five potential reference (housekeeping) genes, namely B2M, HMBS, HPRT1, TBP and UBC, was performed. The expression stability of these genes was assayed using geNorm software application.
RESULTS: The analysis of gene expression data with geNorm identified HPRT1 as the most stable reference gene, followed by UBC and HMBS, for all the investigated tissues. When stratified by disease, the results still pointed at HPRT1 as the gene that retained the greatest robustness in mixed tumors as well as in smooth muscle and stromal sarcomas.
CONCLUSIONS: Our work is the first report on reference gene selection for qRT-PCR applications in mixed tumors, smooth muscle sarcoma and stromal sarcoma of the uterus. A ranking of candidate genes' stability values for the three types of tumors is provided and might serve as a valuable guide for future gene expression studies of these rare entities.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266404     DOI: 10.1016/j.clinbiochem.2012.01.001

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma.

Authors:  Mateusz Bujko; Magdalena Kowalewska; Anna Danska-Bidzinska; Elwira Bakula-Zalewska; Janusz A Siedecki; Mariusz Bidzinski
Journal:  Oncol Lett       Date:  2012-06-22       Impact factor: 2.967

2.  Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells.

Authors:  Silvia Lemma; Sofia Avnet; Manuela Salerno; Tokuhiro Chano; Nicola Baldini
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

3.  Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis.

Authors:  Silvia Lemma; Sofia Avnet; Michael Joseph Meade; Tokuhiro Chano; Nicola Baldini
Journal:  Int J Mol Sci       Date:  2018-09-26       Impact factor: 5.923

4.  Validation of reference genes in Solenopsis invicta in different developmental stages, castes and tissues.

Authors:  Daifeng Cheng; Zhiling Zhang; Xiaofang He; Guangwen Liang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

5.  Selection of suitable reference genes for normalization of quantitative real-time PCR in cartilage tissue injury and repair in rabbits.

Authors:  Xiao-Xiang Peng; Rong-Lan Zhao; Wei Song; Hai-Rong Chu; Meng Li; Shu-Ya Song; Guang-Zhou Li; Dong-Chun Liang
Journal:  Int J Mol Sci       Date:  2012-11-06       Impact factor: 5.923

6.  Integrated omics and gene expression analysis identifies the loss of metabolite-metabolite correlations in small cell lung cancer.

Authors:  Li Yu; Kefeng Li; Zhaoguo Xu; Guoyuan Cui; Xiaoye Zhang
Journal:  Onco Targets Ther       Date:  2018-07-06       Impact factor: 4.147

7.  Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?

Authors:  Laura Gonzalez Dos Anjos; Bruna Cristine de Almeida; Thais Gomes de Almeida; André Mourão Lavorato Rocha; Giovana De Nardo Maffazioli; Fernando Augusto Soares; Isabela Werneck da Cunha; Edmund Chada Baracat; Katia Candido Carvalho
Journal:  Cancers (Basel)       Date:  2018-09-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.